Form 4: Dorman Products SVP Sells Shares Under Pre-Arranged 10b5-1 Plan

Sentiment:

Insider Transaction Report


Dorman Products' SVP and CIO, Donna M. Long, sold 820 shares of common stock on July 28, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • Donna M. Long, Senior Vice President and Chief Information Officer of Dorman Products, Inc. (DORM), reported a sale of common stock.
  • The transaction occurred on July 28, 2025, and was executed pursuant to a Rule 10b5-1(c) plan.
  • A total of 820 shares of common stock were sold in two separate transactions.
  • The first transaction involved the sale of 2 shares at a weighted average price of $121.60 per share, with prices ranging from $121.58 to $121.62.
  • The second transaction involved the sale of 818 shares at a weighted average price of $122.2108 per share, with prices ranging from $121.72 to $122.70.
  • Following these transactions, Donna M. Long beneficially owns 19,073.8738 shares of Dorman Products common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan, which typically indicates a planned liquidity event rather than a reaction to new company-specific information, thus having a neutral sentiment.

Positives

  • The sale was conducted under a Rule 10b5-1 plan, indicating it was a pre-scheduled transaction and not necessarily based on new, non-public information.

Negatives

  • An insider sale, even if pre-planned, reduces the direct ownership stake of a key executive in the company.

Risks

  • No specific risks are detailed in this Form 4 filing beyond the general perception of insider selling, which is mitigated by the 10b5-1 plan.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: A minor reduction in insider ownership, but the pre-planned nature of the sale mitigates concerns about its implications for company performance.

Key Dates

DateDescription
07/28/2025Date of common stock transactions (sales).
07/29/2025Date the Form 4 was signed.

Recommendation

hold

The reported insider sale by Donna M. Long, SVP, CIO, was executed under a Rule 10b5-1 trading plan. Such pre-scheduled transactions are generally not indicative of new material information about the company's performance or outlook. Therefore, this filing alone does not provide a basis for altering an existing investment thesis, suggesting a 'hold' recommendation for investors.

Keywords

Dorman Products, DORM, insider trading, Form 4, stock sale, executive compensation, 10b5-1 plan, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.